Active ingredient
Acamprosate
11 finished FDA listings contain Acamprosate as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- ACAMPROSATE, ACAMPROSATE CALCIUM
- Dosage forms
- Tablet, Delayed Release
- Routes
- Oral
- Manufacturers / labelers
- 10
- Strengths listed
- 333 mg/1
- Brand names in FDA listings
- Acamprosate Calcium
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 82819
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| ANDA 202229 | GLENMARK PHARMS LTD | 2013-07-16 | 3 |
| ANDA 200142 | MYLAN | 2014-03-11 | 2 |
| ANDA 205995 | ZYDUS PHARMS | 2017-05-26 | 3 |
| ANDA 219904 | BIONPHARMA | 2025-09-18 | 2 |
| ANDA 218984 | SOMERSET THERAPS LLC | 2026-03-16 | 1 |
Official labeling on DailyMed
- ACAMPROSATE CALCIUM TABLET, DELAYED RELEASE [SOMERSET THERAPEUTICS, LLC] · version 1 · 2026-08-11
- ACAMPROSATE CALCIUM (ACAMPROSATE CALCIUM ENTERIC-COATED) TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, LLC DBA VANGARD LABS] · version 2 · 2026-06-15
- ACAMPROSATE CALCIUM TABLET, DELAYED RELEASE [REMEDYREPACK INC.] · version 1 · 2026-05-20
- ACAMPROSATE CALCIUM TABLET, DELAYED RELEASE [MAJOR PHARMACEUTICALS] · version 4 · 2026-02-19
- ACAMPROSATE CALCIUM TABLET, DELAYED RELEASE [GLENMARK PHARMACEUTICALS INC., USA] · version 12 · 2026-01-26
- ACAMPROSATE CALCIUM TABLET, DELAYED RELEASE [BIONPHARMA INC.,] · version 1 · 2025-12-02
- ACAMPROSATE CALCIUM (ACAMPROSATE CALCIUM ENTERIC-COATED) TABLET, DELAYED RELEASE [MYLAN PHARMACEUTICALS INC.] · version 12 · 2025-01-15
- ACAMPROSATE CALCIUM TABLET, DELAYED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.] · version 4 · 2023-11-07
- ACAMPROSATE CALCIUM TABLET, DELAYED RELEASE [ZYDUS LIFESCIENCES LIMITED] · version 4 · 2023-11-07
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.